NCT04385680

Brief Summary

The study aims to assess the beneficial value of vaginal preparation with chlorhexidine gluconate 0.05% before cesarean delivery of cases in labor in reduction of postoperative endometritis, fever and wound complications compared to no preparation or using saline only.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
840

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2020

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

May 15, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2022

Completed
Last Updated

September 23, 2022

Status Verified

September 1, 2022

Enrollment Period

1.8 years

First QC Date

May 9, 2020

Last Update Submit

September 22, 2022

Conditions

Keywords

post-cesarean endometritiswound infectionchlorhexidine vaginal preparationchlorhexidine adverse reaction

Outcome Measures

Primary Outcomes (2)

  • post-cesarean endometritis

    uterine fundal tenderness on bimanual examination ( physical examination: suprapubic tenderness, pain elicited by cervical motion, tenderness in parametrium, all during bimanual examination) + with fever (An oral temperature of 38°C or higher within the first 10 days postpartum or 38.7°C within the first 24 hours postpartum) ± purulent lochia requiring antibiotic therapy ( initial antibiotic will be started then waiting for proper therapy according to culture and sensitivity

    First 10 days post-cesarean

  • Postoperative wound infection

    erythema, warmth, tenderness, purulent drainage from the incision site, with or without fever, requiring antibiotic therapy.

    First month after cesarean

Secondary Outcomes (4)

  • Significant leukocytosis

    First 10 days postcesarean

  • Chlorhexidine adverse drug reaction

    First 10 days

  • incidence of hospital readmission

    One month

  • length of hospital stay

    One month

Study Arms (2)

Chlorhexidine vaginal prep.arm

EXPERIMENTAL

Women in labor who will receive vaginal cleaning immediately before cesarean section using 50 ml of chlorhexidine gluconate 0.05% solution and standard abdominal scrub with chlorhexidine gluconate 4%. This concentration is indicated within the British National Formulary for swabbing in obstetrics. A swab soaked in the antiseptic will be used to clean the vagina for 30 seconds prior to CS at the time of urinary catheter insertion by long forceps. After the CS procedure, the vagina is always cleaned of excess blood as with a dry swab.

Drug: Chlorhexidine Gluconate vaginal solution 0.05%

No vaginal antiseptic arm

NO INTERVENTION

Women in labor who will receive abdominal scrub with chlorhexidine gluconate 4% only. Vaginal preparation is not including antiseptic or using normal saline only.

Interventions

preoperative vaginal preparation

Also known as: No preparation or preparation with saline only
Chlorhexidine vaginal prep.arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gestational age ≥28 weeks.
  • Cases had cesarean section after start of labor.

You may not qualify if:

  • Women with known allergy to chlorhexidine gluconate or any of its ingredients.
  • Women with diagnosed group B streptococcus (GBS) colonization.
  • Women with active infection during the procedure.
  • Women did not receive the standard preoperative antibiotic prophylaxis.
  • Women with diagnosis of chorioamnionitis.
  • Prolonged rupture of membranes \>7 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Armed Forces Hospitals Southern Region

Khamis Mushait, 62411, Saudi Arabia

Location

Related Publications (3)

  • Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR. The Increasing Trend in Caesarean Section Rates: Global, Regional and National Estimates: 1990-2014. PLoS One. 2016 Feb 5;11(2):e0148343. doi: 10.1371/journal.pone.0148343. eCollection 2016.

    PMID: 26849801BACKGROUND
  • Zuarez-Easton S, Zafran N, Garmi G, Salim R. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017 Feb 17;9:81-88. doi: 10.2147/IJWH.S98876. eCollection 2017.

    PMID: 28255256BACKGROUND
  • Haas DM, Morgan S, Contreras K, Enders S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2018 Jul 17;7(7):CD007892. doi: 10.1002/14651858.CD007892.pub6.

    PMID: 30016540BACKGROUND

MeSH Terms

Conditions

Wound Infection

Condition Hierarchy (Ancestors)

Infections

Study Officials

  • Ahmed Shafiek

    Armed forces hospitals Southern Region KSA

    PRINCIPAL INVESTIGATOR
  • Hytham Atia

    Armed Forces Hospitals Southern Region

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Obstetrics & Gynecology

Study Record Dates

First Submitted

May 9, 2020

First Posted

May 13, 2020

Study Start

May 15, 2020

Primary Completion

March 10, 2022

Study Completion

August 30, 2022

Last Updated

September 23, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations